Oaktree Acquisition Corp. III Life Sciences

NasdaqGM:OACC.U Stock Report

Market Cap: US$226.5m

Oaktree Acquisition III Life Sciences Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Zaid Pardesi

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

No updates

Recent updates


CEO

Zaid Pardesi (41 yo)

less than a year

Tenure

Mr. Zaid Pardesi serves as Chief Executive Officer of Oaktree Acquisition Corp. III Life Sciences since July 2024 He serves as President and Chief Financial Officer at Oaktree Acquisition Corp. III since F...


Leadership Team

NamePositionTenureCompensationOwnership
Zaid Pardesi
Chief Executive Officerless than a yearno datano data
Courtney Conigliaro
Chief Financial Officerless than a yearno datano data
Mathew Pendo
Chief Operation Officerless than a yearno datano data

0.3yrs

Average Tenure

43yo

Average Age

Experienced Management: OACC.U's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Paul Meister
Independent Directorless than a yearno datano data
John Frank
Independent Chairmanless than a yearno datano data
Alvin Shih
Independent Directorless than a yearno datano data
Aman Kumar
Independent Directorless than a yearno datano data

0.2yrs

Average Tenure

57yo

Average Age

Experienced Board: OACC.U's board of directors are not considered experienced ( 0.2 years average tenure), which suggests a new board.